Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
about
PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasisProtein Kinase D Enzymes as Regulators of EMT and Cancer Cell InvasionAddressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapiesProtein kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity.Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patientsCurrent and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101.Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinomaNav1.5 regulates breast tumor growth and metastatic dissemination in vivoThe phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma.Weight loss reduces basal-like breast cancer through kinome reprogrammingMolecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease.A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancerThe PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.Protein Kinase D1 regulates focal adhesion dynamics and cell adhesion through Phosphatidylinositol-4-phosphate 5-kinase type-l γ.A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cellsMammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming.Cytotoxicity of Salvia miltiorrhiza Against Multidrug-Resistant Cancer Cells.Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.Protein Kinase D family kinases: roads start to segregate.Protein kinase D signaling in cancer: A friend or foe?Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues.Src-mediated tyrosine phosphorylation of Protein Kinase D2 at focal adhesions regulates cell adhesionDNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer.Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.Protein kinase D1: gatekeeper of the epithelial phenotype and key regulator of cancer metastasis?Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.
P2860
Q24303881-EDBDF961-C1F2-46E9-9AAA-087B0F821C49Q26768608-CC85A98C-D26C-4A10-B51A-F1D1F37ABDF9Q28074716-5C86F3DC-B366-4A52-B96F-885A1E5BDF25Q34334430-3B375957-5ED9-42C9-AF77-914B4DAA4D48Q34998421-B65BC711-BAA6-440A-8AC9-F004BF45BEE4Q35000789-DD3E8C85-31D6-4D04-A2CE-A496E2BF3457Q35061372-448F3AFF-2AF2-4325-9D7F-5D2CD964BFCAQ35691035-B71D7536-846D-4AD2-BFBE-D0EAC9E14F0AQ36200052-C911F1FD-016F-43C3-93EE-EFF831C0A86AQ36216177-1D67577F-C914-41D5-9D36-2CBAFCCDCA02Q36545024-4FA3C151-83A5-415A-8C7F-E2E961158332Q36557418-BC34EDAE-1CB1-4A74-9D28-1026D105DB3EQ36758643-E135B474-F75F-406F-B98B-0BF614BEA250Q36821650-D7197A7B-A6EB-499F-8C2B-9FBF88E6ACEAQ37046721-30F3D5AD-BA4E-4B81-A105-1405811D2970Q37271741-186AFEFB-B834-4AFA-9341-B5F868987EE6Q37360359-04CE24BB-DFAB-418B-9738-6609E9F9956FQ37696774-BBE93694-B5B6-4B8A-802F-2C83F592A4C8Q37736010-581A6D28-AB7D-44A0-B174-239A70B84ED4Q38768617-3B9DB11E-F719-4FAE-B77D-006E1961B51AQ38983319-13222671-8887-46FA-A040-514C4EE8479AQ39188751-7C1DFBBE-8964-44D0-8637-CBB55DE259EBQ39348454-18A67611-D370-4346-9D93-5939F5BF6936Q41489966-AFECFBAD-24FB-4EED-914F-9A37B9D97DC8Q41533994-EBA55F49-4C75-4AE5-B470-A34503E3FE39Q47554501-A1BAE460-7AA8-49F1-B759-5851A634617BQ48551091-3777E6B0-8657-4719-A28D-B1F5C6A74963Q49716037-2C258D88-FD29-403D-B6FD-15ED157CEB5DQ49716048-989A00F6-3A63-4FF5-B0D3-32F6CE6E30C1Q54978311-0EB916AC-84ED-4478-97E0-30FC1EEDD185
P2860
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacologic reversion of epi ...... cell invasion and metastasis.
@ast
Pharmacologic reversion of epi ...... cell invasion and metastasis.
@en
type
label
Pharmacologic reversion of epi ...... cell invasion and metastasis.
@ast
Pharmacologic reversion of epi ...... cell invasion and metastasis.
@en
prefLabel
Pharmacologic reversion of epi ...... cell invasion and metastasis.
@ast
Pharmacologic reversion of epi ...... cell invasion and metastasis.
@en
P2093
P2860
P356
P1476
Pharmacologic reversion of epi ...... r cell invasion and metastasis
@en
P2093
Cathy A Andorfer
E Thompson
Edith A Perez
Heike Döppler
Panos Z Anastasiadis
Peter Storz
Sahra Borges
Xochiquetzal J Geiger
P2860
P2888
P356
10.1186/BCR3460
P50
P577
2013-08-23T00:00:00Z
P5875
P6179
1009789557